Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the American College of Rheumatology Convergence 2021

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing